GUIAS HIPERTENSION ARTERIAL.indb - Scc

Revista Colombiana de Cardiología
Febrero 2007
12. Dustan HP, Gifford RW, Frohlich ED, et al. The Third Report of the Joint National
Committee on Detection, Evaluation, and Treatment of High Blood Pressure.
Arch Intern Med 1984; 144: 1045-1057.
13. Wikstrand J, Westergren G, Berglund G, et al. Antihypertensive treatment with
metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a
double-blind international multicenter study. JAMA 1986; 255: 1304-1310.
14. Hannson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive
drugs in elderly patients: cardiovascular mortality and morbidity.
The Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354:
1751-1756.
15. Neaton JD, Grimm RH Jr, Prineas RJ et al. Treatment of mild hypertension study.
Final results. JAMA 1993; 270: 713-724.
16. Messerli FH, Beevers DG, Franklin SS, Pickering TG. Beta-blockers in hypertension:
the emperor has no clothes – an open letter to present and prospective drafters of
new guidelines for the treatment of hypertension. Am J Hypertens 2003; 16: 870-
873.
17. Beevers DG. The end of ß blockers for uncomplicated hypertension? Lancet
2005; 366: 1510-1512.
18. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise
choice? Lancet 2004; 364: 1684-1689.
19. Lindholm LH, Carlberg B, Samuelsson O. Should ß blockers remain the first
choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005;
366: 1545-1553.
20. Dahlöf B, Pennert K, Hannson L. Reversal of left ventricular hypertrophy in
hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens
1992; 5: 95-110.
21. Devereux RB. Do antihypertensive drugs differ in their ability to regress left
ventricular hypertrophy? Circulation 1997; 95: 1983-1985.
22. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis
of the effects of treatment on left ventricular mass in essential hypertension. Am
J Medicine 2003; 115: 41-47.
23. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with
antihypertensive therapies used as first-line agents: a systematic review and
meta-analysis. JAMA 1997; 277: 739-745.
Vol. 13 Suplemento 1
ISSN 0120-5633
223
24. Messerli FH, Grossman E, Goldbourt U. Are â-blockers efficacious as first-line
therapy for hypertension in the elderly?: a systematic review. JAMA 1998; 279:
1903-1907.
25. Goldstein S. â-blockers in hypertensive and coronary heart disease. Arch Intern
Med 1996; 156: 1267-1276.
26. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality
in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
27. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure:
Metoprolol CR/XL randomized intervention trial in congestive heart failure
(MERIT-HF). Lancet 1999; 353: 2001-2007.
28. CIBIS II Investigators and Committees. The cardiac insufficiency study II (CIBIS-II):
a randomized trial. Lancet 1999; 353: 9-13.
29. Lithell HOL.Effect of antihypertensive drugs on insulin, glucose and lipid metabolism.
Diabetes Care 1991; 14: 203-209.
30. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beefers G, de Faire U, et al.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan
Intervention For Endpoint reduction in hypertensive study (LIFE): a randomized
trial against atenolol. Lancet 2002; 359: 1004-1010.
31. Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive
drugs. J Hypertens 2006; 24: 3-10.
32. Alderman MH, Cohen H, Madhavan S. Diabetes and cardiovascular events in
hypertensive patients. Hypertension 1999; 33: 1130-1134.
33. Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose
concentration during antihypertensive treatment as a predictor of myocardial
infarction: population based cohort study. Br Med J 2003; 326: 681.
34. Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S. Randomized,
double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine,
and enalapril in antihypertensive treatment: results of the HANE study.
Br Med J 1997; 315: 154-159.